Article
Impact and effectiveness of pentavalent rotavirus vaccine in children <5 years of age in Burkina Faso.
Vaccine - 12 Nov 2018
Bonkoungou Isidore Juste O, Aliabadi Negar, Leshem Eyal, Kam Madibèlè, Nezien Désiré, Drabo Maxime K, Nikiema Moumouni, Ouedraogo Boureima, Medah Isaïe, Konaté Souleymane, Ouédraogo-Traoré Rasmata, Sangaré Lassana, Kam Ludovic, Yé Diarra, Ouattara Ma, Biey Joseph N, Mwenda Jason M, Tate Jacqueline E, Parashar Umesh D
Abstract excerpt
BACKGROUND: Burkina Faso was one of the first African nations to introduce pentavalent rotavirus vaccine (RV5, RotaTeq) into its national immunization program in October 2013. We describe the impact and effectiveness of rotavirus vaccine on acute gastroenteritis (AGE) hospitalizations among Burkinabe children. METHODS: Sentinel hospital-based surveillance for AGE was conducted at four hospitals during December...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.